IL17A and systemic lupus erythematosus: Additionally, in SLE patients’ T cells, SIRT2 promotes Th17 cell differentiation and inhibits CD4+ T cell production of IL-2, correcting abnormal expression of IL-17A and IL-2, and benefiting CD4+ T cells in lupus prone mice and SLE patients (101).